<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://hdl.handle.net/20.500.12323/4675" />
  <subtitle />
  <id>http://hdl.handle.net/20.500.12323/4675</id>
  <updated>2026-04-04T03:29:51Z</updated>
  <dc:date>2026-04-04T03:29:51Z</dc:date>
  <entry>
    <title>Assessment of the Diagnostic Value of IL-10 and Lactoferrin by BIRADS Categories in Breast Neoplasms</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/4684" />
    <author>
      <name>Orujova, Ilaha</name>
    </author>
    <author>
      <name>Asadov, Ajdar</name>
    </author>
    <author>
      <name>Alakberzade, Shafiqa</name>
    </author>
    <author>
      <name>Orujov, Agil</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/4684</id>
    <updated>2020-08-19T14:25:04Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Assessment of the Diagnostic Value of IL-10 and Lactoferrin by BIRADS Categories in Breast Neoplasms
Authors: Orujova, Ilaha; Asadov, Ajdar; Alakberzade, Shafiqa; Orujov, Agil
Abstract: Breast cancer is the most common cancer among women around the world. The&#xD;
real way to improve the results of treatment of breast tumours is an early, and in&#xD;
some cases, preclinical diagnosis. This problem can only be solved if complex&#xD;
diagnostic methods are used. The aim of our work is to determine the change in the&#xD;
level of IL-10 and lactoferrin in the blood serum of patients with breast neoplasms&#xD;
corresponding to the BIRADS categories. The sensitivity, specificity, diagnostic&#xD;
values of these biochemical parameters and the correlation between them were also&#xD;
studied. According to the results of our studies, increasing levels of BIRADS&#xD;
would lead to a raise in the levels of IL-10 and lactoferrin in blood serum in&#xD;
patients with breast tumours. The results showed that lactoferrin had a high&#xD;
diagnostic value compared to IL-10.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Azerbaijan Republic</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/4683" />
    <author>
      <name>Saltanat, Aghayeva</name>
    </author>
    <author>
      <name>Ayaz, Mammadov</name>
    </author>
    <author>
      <name>Arndt, Rolfs</name>
    </author>
    <author>
      <name>Volha, Skrahina</name>
    </author>
    <author>
      <name>Elkhan, Rasulov</name>
    </author>
    <author>
      <name>Elvira, Guliyeva</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/4683</id>
    <updated>2020-08-19T14:22:16Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Azerbaijan Republic
Authors: Saltanat, Aghayeva; Ayaz, Mammadov; Arndt, Rolfs; Volha, Skrahina; Elkhan, Rasulov; Elvira, Guliyeva
Abstract: Genetic screening of school children in Masalli region in Azerbaijan Republic identified 23&#xD;
school children with G6PD enzyme activity different deficiency (from 0 up to 60%&#xD;
activity). Biochemical studies were done/performed for school children with activity&#xD;
efficiency on enzyme preparations from erythrocytes. As to WHO Guidelines, enzymatic&#xD;
preparations were related to the following classes: 2nd class – 13 boys, 3rd class – 6 school&#xD;
boys, 4th class – 4 of them. DNA molecular analysis, isolated from blood of the index&#xD;
patient, was classified as the 2nd class of G6PD enzyme deficiency and has shown the&#xD;
substitution of Guanine nucleotide with Adenine in position 1178. As a result of the&#xD;
mutation in protein in the position 393, substitution of amino acids Arginine with Histidine&#xD;
[G6PD,1178 (G-A) Arg393His] takes place.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Biological Characteristics of Schmallenberg Virus - an Overview</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/4682" />
    <author>
      <name>Zeynalova, Shalala</name>
    </author>
    <author>
      <name>Omarov, Asaf</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/4682</id>
    <updated>2020-08-19T14:16:36Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Biological Characteristics of Schmallenberg Virus - an Overview
Authors: Zeynalova, Shalala; Omarov, Asaf
Abstract: Schmallenberg virus disease was originally reported in Germany in 2011. The new disease&#xD;
was diagnosed in the UK in January 2012. Currently, little information has been collected&#xD;
about the pathogen of the Schmallenberg virus. The virus genetically belongs to the&#xD;
Bunyaviridae family (Orthobunyavirus genus and Simbu serogroup). The clinical&#xD;
symptoms of acute SBV infection are unspecific in sheep and goats. This study&#xD;
characterized the origin, emergence, transmission, spread in Europe and Azerbaijan,&#xD;
clinical signs, and the diagnosis of this virus. Currently, the Shmallenberg disease is known&#xD;
to be a serious threat to Veterinary Public Health.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Cytokines and Peri-Implant Disease</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/4681" />
    <author>
      <name>Adli, Hawa</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/4681</id>
    <updated>2020-08-19T14:13:15Z</updated>
    <published>2020-01-01T00:00:00Z</published>
    <summary type="text">Title: Cytokines and Peri-Implant Disease
Authors: Adli, Hawa
Abstract: The aim of this review was to summarize data from studies making inquiries on levels of&#xD;
the cytokines in pathogenesis of peri-implant diseases. Here we reviewed the recent&#xD;
developments on IL-1β, IL-10, IL-17, IL-21, and IL-33. We highlighted recent advances&#xD;
during the last few years in this area and discussed their roles in immune regulation in&#xD;
patients with peri-implant disease.Our results revealed that identifying the levels of these&#xD;
cytokines (IL-1β, IL-10, IL-17, IL-21, and IL-33) may help to predict the diagnosis of periimplant&#xD;
diseases. From a safety perspective, this study emphasized the need to consider the&#xD;
impact of these interleukin on peri-implant diseases.</summary>
    <dc:date>2020-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

